OHIO 31-0121318
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
|
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to the filing requirements for at least the past 90 days. YES X NO
State the number of shares outstanding of each of the registrant's classes of common equity, as of the latest practicable date: [1,822,816] shares of Common Stock, without par value, were outstanding at November 2, 2001.
PAGE NO.
--------
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements.
Balance Sheets as of September 30, 2001 (unaudited)
and December 31, 2000 3 - 4
Statements of Operations For the Three Months and Nine
Months Ended September 30, 2001 and 2000 (unaudited) 5
Statements of Cash Flows For the Nine Months
Ended September 30, 2001 and 2000 (unaudited) 6 - 7
Notes to Financial Statements (unaudited) 8 - 11
Item 2. Management's Discussion and Analysis of Financial
Condition and Results of Operations. 12 - 16
Item 3. Quantitative and Qualitative Disclosures About Market Risk N/A
PART II. OTHER INFORMATION
Item 1. Legal Proceedings. N/A
Item 2. Changes in Securities and Use of Proceeds. N/A
Item 3. Defaults Upon Senior Securities. N/A
Item 4. Submission of Matters to a Vote of Security Holders. N/A
Item 5. Other Information. N/A
Item 6. Exhibits and Reports on Form 8-K. 17
Signatures. 18
|
SEPTEMBER 30, DECEMBER 31,
ASSETS 2001 2000
------ ---- ----
(UNAUDITED)
CURRENT ASSETS
Cash $ 292,418 $ 202,406
Accounts and notes receivable
Trade, less allowance for doubtful accounts of $17,000 and
$26,000, respectively 379,844 386,567
Related party receivables -- 4,283
Contract research receivables, current 33,334 --
Employees 15,638 --
Other 12,086 --
Inventories 881,164 617,468
Prepaid expenses 11,149 39,766
---------- ----------
Total current assets 1,625,633 1,250,490
---------- ----------
PROPERTY AND EQUIPMENT,
AT COST
Machinery and equipment 2,173,038 1,959,086
Furniture and fixtures 18,122 15,250
Leasehold improvements 338,406 305,586
---------- ----------
2,529,566 2,279,922
Less accumulated depreciation 1,857,322 1,701,150
---------- ----------
672,244 578,772
---------- ----------
OTHER ASSETS
Intangibles 41,400 38,688
---------- ----------
TOTAL ASSETS $2,339,277 $1,867,950
========== ==========
|
The accompanying notes are an integral part of these financial statements.
SEPTEMBER 30, DECEMBER 31,
LIABILITIES AND SHAREHOLDERS' EQUITY 2001 2000
------------------------------------ ---- ----
(UNAUDITED)
CURRENT LIABILITIES
Capital lease obligation, current portion $ 40,765 $ 26,279
Note payable shareholders, current portion 28,000 10,869
Accounts payable 395,750 294,028
Accounts payable, shareholders 6,013 1,803
Accrued expenses 280,881 156,916
----------- -----------
Total current liabilities 751,409 489,895
----------- -----------
CAPITAL LEASE OBLIGATION, NET OF
CURRENT PORTION 114,917 57,965
----------- -----------
NOTE PAYABLE SHAREHOLDERS, NET OF CURRENT
PORTION 90,270 121,401
----------- -----------
REDEEMABLE CONVERTIBLE PREFERRED
STOCK (Series A)
10% cumulative, nonvoting, no par value, $1,000 stated
value, liquidation and mandatory redemption at
stated value per share plus unpaid and accumulated
dividends $75.00 and $260.96, respectively 104,820 87,658
----------- -----------
SHAREHOLDERS' EQUITY
Convertible preferred stock, Series B, 10% cumulative,
nonvoting, no par
value, $10 stated value, optional
redemption at 103% 358,085 338,424
Common stock, no par value, authorized 15,000,000
shares; 1,821,926 and 1,816,977 shares issued and outstanding,
respectively 6,358,816 6,334,696
Additional paid-in capital 60,369 98,187
Accumulated deficit (5,499,409) (5,660,276)
----------- -----------
1,277,861 1,111,031
----------- -----------
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $ 2,339,277 $ 1,867,950
=========== ===========
|
The accompanying notes are an integral part of these financial statements.
THREE MONTHS ENDED NINE MONTHS ENDED
SEPT. 30 , SEPT. 30 , SEPT. 30 , SEPT. 30 ,
2001 2000 2001 2000
---- ---- ---- ----
SALES REVENUE $ 820,044 $ 679,635 $ 2,511,154 $ 1,877,313
CONTRACT RESEARCH REVENUE 71,769 115,042 345,910 417,079
---------- ----------- ----------- -----------
891,813 794,677 2,857,064 2,294,392
---------- ----------- ----------- -----------
COST OF SALES REVENUE 513,250 525,102 1,585,659 1,484,707
COST OF CONTRACT RESEARCH REVENUE 42,369 83,715 266,055 322,143
---------- ----------- ----------- -----------
555,619 608,817 1,851,714 1,806,850
---------- ----------- ----------- -----------
GROSS MARGIN 336,194 185,860 1,005,350 487,542
GENERAL AND ADMINISTRATIVE EXPENSES 244,708 128,807 652,320 352,018
SALES AND PROMOTIONAL EXPENSES 52,249 86,896 178,344 219,131
---------- ----------- ----------- -----------
INCOME (LOSS) FROM OPERATIONS 39,237 (29,843) 174,686 (83,607)
---------- ----------- ----------- -----------
OTHER INCOME (EXPENSE)
Interest, net (3,291) (16,438) (13,571) (50,071)
Miscellaneous, net (298) (4,295) (249) 1,409
---------- ----------- ----------- -----------
(3,589) (20,733) (13,820) (48,662)
---------- ----------- ----------- -----------
INCOME (LOSS) BEFORE INCOME TAX 35,648 (50,576) 160,866 (132,269)
INCOME TAX EXPENSE -- -- -- --
---------- ----------- ----------- ------------
NET INCOME (LOSS) 35,648 (50,576) 160,866 (132,269)
DIVIDENDS ON PREFERRED STOCK (9,360) (1,017) (28,081) (52,688)
ACCRETION OF REDEEMABLE CONVERTIBLE
PREFERRED (SERIES A) (3,881) (2,929) (9,737) (8,785)
---------- ----------- ----------- -----------
INCOME (LOSS) APPLICABLE TO COMMON SHARES $ 22,407 $ (54,522) $ 123,048 $ (193,742)
========== =========== =========== ===========
EARNINGS PER SHARE - BASIC AND DILUTIVE (Note 2)
NET INCOME (LOSS) PER COMMON SHARE
Basic $ 0.01 $ (0.04) $ 0.07 $ (0.14)
========== =========== =========== ===========
Diluted $ 0.01 $ (0.04) $ 0.07 $ (0.14)
========== =========== =========== ===========
WEIGHTED AVERAGE SHARES OUTSTANDING
Basic 1,821,926 1,363,050 1,820,618 1,361,879
========== =========== =========== ===========
Diluted 1,821,926 1,363,050 1,820,618 1,361,879
========== =========== =========== ===========
|
The accompanying notes are an integral part of these financial statements.
SEPTEMBER 30, SEPTEMBER 30
2001 2000
---- ----
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss) $ 160,866 (132,269)
--------- ---------
Adjustments to reconcile net income (loss) to net cash provided by
operating activities:
Depreciation 156,171 219,739
Amortization 1,838 --
Inventory reserve (20,059) 51,427
Provision for doubtful accounts (9,000) 19,589
Changes in operating assets and liabilities:
(Increase) decrease in assets:
Accounts receivable (41,052)
Inventories (243,637) (46,799)
Prepaid expenses 28,617 (126,086)
Other assets (4,550) (43,690)
Increase (decrease) in liabilities: (498)
Accounts payable 124,932 147,626
Accrued expenses 123,966 (664)
--------- ---------
Total adjustments 117,226 220,644
--------- ---------
Net cash provided by operating activities 278,092 88,375
--------- ---------
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property and equipment (151,732) (62,205)
--------- ---------
Net cash used in investing activities (151,732) (62,205)
--------- ---------
CASH FLOWS FROM FINANCING ACTIVITIES
Bank overdraft -- (30,735)
Proceeds on notes payable, bank -- 75,000
Principal repayments on notes payable, bank -- (95,025)
Principal repayments on long-term debt, shareholder (14,000) --
Proceeds from subordinated notes payable -- 89,408
Principal payments on capital lease obligation (26,473) (60,031)
Proceeds from exercise of common stock options 4,125 --
Proceeds from the sale of common stock -- 79,800
Redemption of Series A preferred stock -- (70,125)
--------- ---------
Net cash used in financing activities (36,348) (11,708)
--------- ---------
|
The accompanying notes are an integral part of these financial statements.
SEPTEMBER 30, SEPTEMBER 30,
2001 2000
---- ----
NET INCREASE IN CASH 90,012 14,462
CASH - Beginning of period 202,406 --
-------- --------
CASH - End of period $292,418 $ 14,462
======== ========
SUPPLEMENTAL DISCLOSURES OF CASH
FLOW INFORMATION
Cash paid during the period for:
Interest $ 16,767 $ 12,903
Income taxes $ -- $ --
SUPPLEMENTAL DISCLOSURES OF NONCASH
INVESTING AND FINANCING ACTIVITIES
Common stock was issued as partial payment for accounts payable $ 19,000 $ --
Preferred stock, series A converted to common stock $ -- $ 8,275
Property and equipment was purchased by capital lease $ 97,911 --
|
The accompanying notes are an integral part of these financial statements.
NOTE 1. BUSINESS ORGANIZATION AND PURPOSE
Superconductive Components, Inc. (the Company) is an Ohio corporation that was incorporated in May 1987. The Company was formed to develop, manufacture and sell materials using superconductive principles. Operations have since been expanded to include the manufacture and sale of non-superconductive materials. The Company's domestic and international customer base is primarily in the research, education, electronics and functional coatings industries.
NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The accompanying unaudited financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with instructions to Form 10-QSB and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments considered necessary for fair presentation of the results of operations for the periods presented have been included. The financial statements should be read in conjunction with the audited financial statements and the notes thereto for the fiscal year ended December 31, 2000. Interim results are not necessarily indicative of results for the full year.
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expense during the reporting period. Actual results could differ from those estimates.
NOTE 3. INVENTORY
Inventory is comprised of the following:
September 30, December 31,
2001 2000
---- ----
(unaudited)
Raw materials $580,264 $413,657
Work-in-progress 113,666 111,978
Finished goods 228,175 152,833
Inventory reserve (40,941) (61,000)
-------- --------
$881,164 $617,468
======== ========
|
NOTE 4. COMMON STOCK AND STOCK OPTIONS
During the nine months ended September 30, 2001, the Company paid cash of $12,500 and issued 19,000 shares of common stock of the Company at a subscription price of $1.00 per share to Taratec Corporation for services rendered to the Company. The President of Taratec, Mr. Ungar, is a director of the Company. The fair market value of the common stock issued at the date of issuance was $1.34 per share, or a discount of 25%. The Company issued the shares at a discounted price as the shares were unregistered and, therefore, limited as to marketability for sale until the securities were registered under the Securities Act of 1933 or an applicable exemption from registration thereunder.
During the nine months ended September 30, 2001, common stock options totaling 750 shares were converted to common stock at a price of $2.50 for total cash proceeds of $1,875. Additionally, 199 shares of common stock were converted from Series B preferred stock.
The following options were granted under the 1995 Stock Option plan during the period:
GRANT DATE # OPTIONS GRANTED OPTION PRICE ---------- ----------------- ------------ January 15, 2001 5,000 $1.34 March 7, 2001 25,000 $1.88 April 23, 2001 15,000 $2.00 |
On April 2, 2000 options totaling 10,000 shares at $1.30 per share were granted under the 1995 Non-Statutory Stock Option Plan to the Company President in connection with his guarantee of certain lease financing to the Company.
NOTE 5. EARNINGS PER SHARE
Basic income per share is calculated as income available to common shareholders divided by the weighted average of common shares outstanding. Diluted earnings per share is calculated as diluted income available to common shareholders divided by the diluted weighted average number of common shares. Diluted weighted average number of common shares has been calculated using the treasury stock method for Common Stock equivalents, which includes Common Stock issuable pursuant to stock options and Common Stock warrants. The following is provided to reconcile the earnings per share calculations:
Three months ended Sept 30, Nine months ended Sept 30,
2001 2000 2001 2000
---- ---- ---- ----
Income (loss)
applicable to
common shares $ 22,407 $ (54,522) $ 123,048 $ (193,742)
========== ========== ========== ==========
Weighted average
common shares
outstanding -
basic 1,821,926 1,363,050 1,820,618 1,361,879
Effect of dilutive
stock options -- -- -- --
---------- ---------- ---------- ----------
Weighted average
shares outstanding
diluted 1,821,926 1,363,050 1,820,618 1,361,879
========== ========== ========== ==========
|
NOTE 6. SEGMENT INFORMATION
The Company is managed in two operating segments: Target Materials, Inc. ("TMI") and the SCI Division ("SCI"). While the Company has international sales, in the past management did not separately identify and evaluate financial information pertaining to sales outside the United States; therefore, revenue by geographic location is not available for 2000. For 2001, management has implemented processes to track this data.
Corporate operations include administrative and sales functions. Corporate assets include cash and general fixed assets.
Note 6. Segment Information (Continued)
The following is a summary of key segment information for the nine months ended September 30, 2001. As noted previously, international sales data is not available for the nine months ended September 30, 2000.
NINE MONTHS ENDED SEPTEMBER 30, 2001
------------------------------------
SCI TMI CORPORATE TOTAL
--- --- --------- -----
Revenues:
U.S. $ 754,182 $ 1,677,053 $ -- $ 2,431,235
International 130,410 295,419 -- 425,829
----------- ----------- ----------- -----------
Total 884,592 1,972,472 -- 2,857,064
Segment profit
(loss) 132,841 526,433 (498,408) 160,866
Interest expense -- -- 17,529 17,529
Depreciation and
amortization 45,910 30,217 81,882 158,009
Segment assets 633,197 1,511,960 194,120 2,339,277
Expenditures for
segment assets 58,397 119,513 71,733 249,643
NINE MONTHS ENDED SEPTEMBER 30, 2000
------------------------------------
Revenues
$ 888,965 $ 1,405,427 $ -- $ 2,294,392
Segment profit
(loss) 124,814 124,378 (381,461) (132,269)
Interest expense -- -- 50,071 50,071
Depreciation and
amortization 38,439 20,426 160,874 219,739
Segment assets 620,444 954,706 80,074 1,655,224
Expenditures for
segment assets 33,274 20,788 8,143 62,205
|
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS
The following discussion should be read in conjunction with the Financial Statements and Notes contained herein.
The following section contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that express, or involve discussions as to expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, through the use of words or phrases such as "will likely result", "are expected to", "will continue", "is anticipated", "estimated", "projection", "outlook') are not statements of historical fact and may be forward looking. Forward-looking statements involve estimates, assumptions and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements. These forward-looking statements are based largely on the Company's expectations and are subject to a number of risks and uncertainties, including but not limited to economic, competitive, regulatory, growth strategies, available financing and other factors discussed elsewhere in this report and in other documents filed by the Company with the SEC, including in the Company's 10-KSB for the year ended December 31, 2000, at pages 22 through 25. Many of these factors are beyond the Company's control. Actual results could differ materially from the forward-looking statements made. In light of these risks and uncertainties, there can be no assurance that the results anticipated in the forward-looking information contained in this report will, in fact, occur.
Any forward-looking statement speaks only as of the date on which such statement is made, and the Company undertakes no obligation to update any forward-looking statement or statements to reflect events or circumstances after the date on which such statements are made or reflect the occurrence of unanticipated events, unless necessary to prevent such statements from becoming misleading. New factors emerge from time to time and it is not possible for management to predict all factors, nor can it assess the impact of each such factor on the business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.
To date, the Company has received revenue predominantly from commercial sales, government research contracts and non-government research contracts. The Company has incurred cumulative losses of $5,499,409 from inception to September 30, 2001.
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS (CONTINUED)
Nine months ended September 30, 2001 (unaudited) compared to nine months ended September 30, 2000 (unaudited):
Revenues for the nine months ended September 30, 2001 were $2,857,064 compared to $2,294,392 last year, an increase of $562,672 or 24.5%.
TMI division revenues increased 40.3% to $1,972,472 in 2001 from $1,405,427 in 2000. The increase is partially due to $280,000 in sales of tantalum and increases related to additional sales and marketing.
SCI division product revenues increased 14.2% to $538,682 from $471,886 the prior year. The increase is due to continued growth of its ceramic sputtering target business.
SCI division contract research revenues were $345,910 in 2001 compared to $417,079 in 2000. The research contract for NASA expired in 2001. This contract generated $70,454 in revenues in the first quarter of this year.
The Company was awarded a $100,000 Small Business Innovation Research Phase I grant from the National Science Foundation in January 2001. The purpose of this grant was to develop a novel method for making ultra-fine particles of phase pure (nanocrystalline) strontium ruthenate (SrRuO3) utilizing new coordination compounds. The initial grant ended in third quarter 2001.
During third quarter 2001 the Company was awarded an extension to a Phase II Small Business Innovation Research grant for $300,000 from the National Science Foundation. This award is to develop an advanced method to manufacture continuous reacted lengths of High Tc Superconductor: Bismuth Strontium Calcium Copper Oxide - 2212 Wire. This contract generated $46,154 in revenues in the third quarter of this year.
Gross margin in 2001 was $1,005,350 or 35.2% of total revenues compared to $487,542 or 21.2% of total revenues in 2000.
Gross margin, expressed as a percentage of sales revenues for TMI division was 38.7% in 2001 versus 25.4% in 2000. The improvement in gross margin is due primarily to increased sales as the gross margin benefited from better utilization of production capacity.
Gross margin on sales revenues for SCI Division product sales was 30.1% in 2001 compared to 18.6% in 2000. The change is due to a change in product mix driven by an increase in sales of ceramic targets.
Gross margin on SCI division contract research revenues was 23.1% for 2001 compared to 22.8% in 2000.
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS (CONTINUED)
Selling expense in 2001 declined to $178,344 from $219,131 in 2000, a decrease of 18.6%. The lower selling costs is due to a reduction of sales staff.
General and administrative expense in 2001 increased 85.3% to $652,320 from $352,018. The increase is principally due to additional expenses for preparing filings for regulatory agencies and increased payroll costs.
Internal research and development costs are expensed as incurred. Research and development costs, including testing, for 2001 were $125,070 compared to $105,081 in 2000. Internal research and development costs increased due to additions in staff.
Interest expense was $17,529 for the nine months ended September 30, 2001 compared to $50,071 the prior year, a reduction of 65.0% due to lower bank borrowings.
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS (CONTINUED)
Net income (loss) per common share based on the income (loss) applicable to common shares for the nine months ended September 30, 2001 and 2000 was $0.07 and $(0.14), respectively. The income (loss) applicable to common shares includes the net income (loss) from operations, Series A and B preferred stock dividends and the accretion of Series A preferred stock. The net income (loss) per common share from operations was $0.09 and $(0.10), respectively. The difference between the net income (loss) from operations and the loss applicable to common shares of $(0.02) and $(0.04), respectively, is a result of the position that the preferred shareholders have in comparison to the common shareholders.
Dividends on the Series A and B preferred stock accrue at 10% annually on the outstanding shares. Dividends on the Series A preferred stock totaled $7,425 for nine months of 2001 and $7,471 for the comparable period last year. Dividends on the Series B preferred stock totaled $20,656 in 2001 and $57,681 last year.
The accretion of Series A preferred stock represents issuance costs of $70,277 that were netted against the proceeds of Series A preferred stock. The issuance costs are being amortized on a straight-line basis over the payout period of seven years of income (loss) applicable to common shares and additional paid-in capital. The accretion for the nine months ended September 30, 2001 was $9,737 as compared to $8,785 for the nine months ended September 30, 2000.
For the nine months ended September 30, 2001, basic and diluted earnings per common share were $0.07. Weighted average common shares outstanding totaled 1,820,618 for the basic and diluted methods.
For the nine months ended September 30, 2000, basic and diluted loss per common share were $(0.14) per share. Weighted average common shares outstanding totaled 1,361,879 for the basic and diluted methods.
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS (CONTINUED)
At September 30, 2001, working capital was $874,224 compared to $165,796 at September 30, 2000. The Company provided cash from operations for the nine months ended September 30, 2001 and 2000 of approximately $278,000 and $88,000, respectively. Significant non-cash items including depreciation and inventory reserve on excess and obsolete inventory were approximately $138,000 and $271,000, respectively, for the nine months ended September 30, 2001 and 2000. Overall, accounts receivable, inventory, prepaids and other assets increased in excess of accounts payable and accrued expenses by approximately $12,000 and $70,000 at September 30, 2001 and 2000, respectively, as a result of timing of receipt of inventory versus required scheduled payments on this inventory.
For investing activities, the Company used cash of approximately $152,000 and $62,000 for the first nine months of 2001 and 2000, respectively. The amounts invested were used to purchase machinery and equipment for increased production capacity.
The Company used cash of approximately $36,000 for financing activities during the nine months ended September 30, 2001. Cash payments to third parties for capital lease obligations approximated $26,000; cash payments on shareholder notes totaled $14,000; and cash proceeds from the exercise of stock options totaled $4,125.
The Company used cash of approximately $12,000 for financing activities during the nine months ended September 30, 2000. Due to tight cash flow in the prior year, the Company used approximately $31,000 to decrease the amount of overdrawn cash. Cash payments to third parties for debt and capital lease obligations approximated $155,000. Proceeds from the sale of common stock totaled $79,800. Payments for principal and cumulative dividends on Series A Preferred Shares totaled $70,125.
Officers of the Company have advanced funds in the form of notes payable and accounts payable and have guaranteed bank debt. There is no commitment by these individuals to continue funding the Company or to guarantee bank debt in the future. However, the Company believes that its current operations and pursuit of new financing arrangements will allow management to continue its current plans. Nevertheless, the Company cannot be certain that it will be successful in efforts to raise additional new funds.
INVESTORS ARE REFERRED TO AND SHOULD SPECIFICALLY CONSIDER THE RISKS AND SPECULATIVE FACTORS INHERENT IN AND AFFECTING THE BUSINESS OF THE COMPANY AND THE COMPANY'S COMMON STOCK AS SET FORTH IN THE COMPANY'S FORM 10-KSB FOR THE YEAR ENDED DECEMBER 31, 2000, AT PAGES 22 THROUGH 25.
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K.
(A) EXHIBITS.
EXHIBIT EXHIBIT
NUMBER DESCRIPTION
------ -----------
3(a) * Amended and Restated Articles of Incorporation of Superconductive Components, Inc.
3(b) * Restated Code of Regulations of Superconductive Components, Inc.
10(a) * Lease Agreement between Superconductive Components, Inc. and University Area
Rentals dated as of February 7, 1997.
10(b) * Subcontract Agreement between Superconductive Components, Inc. and The Ohio State
University effective as of April 1, 2000.
10(c) * 1987 Incentive Stock Option Plan.
10(d) * 1991 Non-Statutory Stock Option Plan.
10(e) * 1995 Stock Option Plan.
10(f) ** License Agreement with Sandia Corporation dated February 26, 1996.
10(g) ** Nonexclusive License with The University of Chicago (as Operator of Argonne National
Laboratory) dated October 12, 1995.
10(h) ** Nonexclusive License with The University of Chicago (as Operator of Argonne National
Laboratory) dated October 12, 1995.
10(i) ** Sales Distribution Agreement with Earth Chemical Co., Ltd.
10(j) ** National Aeronautics Space Administration Contract dated April 8, 1999.
10(k) ** National Science Foundation award dated August 26, 1999.
10(l) ** National Science Foundation award dated November 27, 2000.
10(m) ** 10% Subordinated Promissory Note dated March 1, 1993.
|
* Filed with the Company's initial Form 10-SB on September 28, 2000. ** Filed with the Company's Form 10-SB Amendment No. 1 on January 3, 2001.
(B) REPORTS ON FORM 8-K.
None.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this amended report to be signed on its behalf by the undersigned thereunto duly authorized.
SUPERCONDUCTIVE COMPONENTS, INC.
Date: November 14, 2001 /s/ Edward R. Funk
---------------------------------------------
Edward R. Funk, President and Chief Executive
Officer
Principal Executive Officer and Principal Financial
Officer)
|